Overview

Liraglutide for Low-responders After Bariatric Surgery

Status:
Withdrawn
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
To study the effect of Liraglutide (3.0 mg daily) on 9-month weight loss in low responders 3-months after bariatric surgery.
Phase:
N/A
Details
Lead Sponsor:
Zuyderland Medisch Centrum
Collaborator:
Nederlandse Obesitas Kliniek
Treatments:
Liraglutide